Has UnitedHealth Stock Become A Different Bet?
For questions about this article or underlying research, email help@trefis.com.
UnitedHealth Group (UNH) stock trades at 23.1 times its earnings over the last twelve months, putting it close to the 22.8 multiple for the S&P 500. Shareholders paying a market multiple need to know what they are buying, and the company’s message has changed. In mid-2025, management emphasized that its prices had fallen short of its members’ medical costs. On the latest call, management emphasized something different. So what is it?
UnitedHealth Now Talks Up AI And Modernization
Management now emphasizes artificial intelligence and modernizing how the company runs. On the October 13, 2026 call, management said AI-enabled capabilities are beginning to help clinicians spend more time with patients. AI chart summarization now reaches more than 40% of the company’s employed clinicians. Pricing still came up, but management framed it as a discipline rather than a shortfall.
That is a long way from the fiscal Q2 2025 call on July 29, 2025. At the time, management said its pricing assumptions were well short of actual medical costs. Just three months earlier, during the fiscal Q1 2025 call, management had called the company’s overall performance unusual and unacceptable.
This new emphasis is good news only if UnitedHealth now prices its plans to cover those costs. In the latest quarter, it appears to be moving in that direction. UnitedHealth reported a 5.8% operating margin in fiscal Q3 2026, up from 3.8% in fiscal Q3 2025. Over the full twelve months, however, the 5.3% operating margin remains below the 6.1% recorded a year before.
Is UnitedHealth’s AI Push Big Enough To Matter Yet?
It is not big enough in revenue yet. UnitedHealth builds its AI products to sell within Optum Insight, where management said investment has focused on healthcare-specific AI solutions. Optum Insight brought in $19.4 billion in fiscal 2025, up 3.5% from a year earlier. Meanwhile, UnitedHealthcare, the insurance business management repriced, brought in $345 billion that year, up 15.7%. The business behind the new emphasis is a small fraction of the one behind the old worry, and it grew far more slowly in fiscal 2025.
The client count tells a more recent story. Management said an AI offering launched at the end of 2025 had two clients at that point. By the October call, 15 clients had it in place and another 24 were putting it in. Management expects 2027 to show meaningful progress at Optum Insight, laying the foundation for faster growth in 2028 and beyond.
Should UnitedHealth Holders Be Reassured By The New Emphasis?
Mostly, yes. Management is talking up AI in a year when each quarter has brought UnitedHealth a wider operating margin than the last two quarters of 2025. This means the new emphasis has not taken the place of the pricing work. Those two late-2025 quarters had operating margins of only 3.8% and 0.3%.
UnitedHealth’s company-wide medical care ratio, which measures medical costs as a share of premiums, improved to 88.4% in the quarter from 89.9% a year earlier. Commercial plans are the weak spot. Management said cost trends there were running above the 11% it had first expected. Management also said those pressures will stretch out its ability to reach its long-term margins in the commercial business.
If UnitedHealth prices its commercial plans short of their costs, Optum Insight’s AI work is too small to make up for it today. Management also plans to step up modernization spending at UnitedHealthcare and Optum Insight, a move it counts as a headwind.
So far, UnitedHealth is pricing its plans closer to its costs than a year ago. Its AI work is less far along, with clients but little revenue to show. The stock is therefore still mostly a bet on pricing, not yet on AI. When UnitedHealth reports fourth-quarter results, expected in January 2027, Optum Insight’s revenue growth will show whether that is starting to change.
Who Is Watching Your Portfolio’s Risk When You’re Not?
UnitedHealth Group is one risk to keep an eye on, and most portfolios hold many. Watching all of them, day after day, is hard to do alone. Our partner advisory firm builds portfolios on Trefis research, starting with the HQ Portfolio, whose edge has been limiting losses when markets fall. Talk it through on a free 30-minute call, and bring your hardest questions.
Spot an error or want more like this? Tell us in 10 seconds.